Venus Remedies’ antibiotic product receives US Patent

12 Jun 2012 Evaluate

Venus Remedies has received patent from the US Patent Office for a breakthrough antibiotic product. The new drug product CSE 1034 which is an antibiotic adjuvant entity (AAE), has been found to be effective against a wide range of drug resistant infections including the ‘superbugs’ like carbapenemase resistant Metallobetalactamses (MBL) strains.

The US patent of CSE 1034 for the company is a landmark development for initiating the process of commercialization of this novel drug, designed specifically to target growing bacterial resistance mechanisms. There are far fewer new antibiotics in the development pipeline as global drug makers are focusing more on drug candidates with instant block-buster potential to treat cancer and metabolic diseases.

In view of the urgency, the regulatory agencies around the world are currently fast-tracking the approval process at antibiotic drugs. Even the Infectious Diseases Society of America (IDSA) has recommended the US Food and Drug Administration (USFDA) to review drugs designed to target antibiotic resistance as ‘orphan drugs’ to speed up their marketing approval.

Besides, Venus drug has a unique profile of action which gives it an edge over all the existing therapies. This unique antibiotics adjuvant entity creates a synergistic effect due to its activity on AMRINGER (Acquired Multiple Resistance in Gram Negative Enterococci and Rods) which stops development and spread of bacterial resistance. This drug is experienced with clinical studies on more than 1000 patients which have indicated approximately 20-30% reduction in cost of therapy compared to conventional therapies being used.

Further, the company is planning to launch this drug in India under the brand name ‘ELORES’ and is planning to have a pre IND meeting with USFDA for fast track approval of this product.

Venus Remedies Share Price

745.20 -7.70 (-1.02%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×